Endocrinology Test
|
|
| 1. Aldosterone release is responsible for: |
|
|
| 2. Which of the following is the principal inhibitor of prolactin: |
|
|
| 3. The confirmatory marker of Graves’ disease is: |
|
|
| 4. Parathyroid hormone: |
|
|
| 5. The medical treatment in microprolactinomas: |
|
|
| 6. In cases of glucocorticoid excess suspicion confirmation tests are made with: |
|
|
| 7. Which of the following statements regarding corticotropin-releasing hormone are true: |
|
|
| 8. The endocrine complications of corticotherapy are: |
|
|
| 9. Laboratory exam in Graves’ disease shows: |
|
|
| 10. In pregnant women with untreated hypothyroidism the following are valid: |
|
|
| 11. Type II of primary osteoporosis: |
|
|
| 12. In pituitary tumors with compression of the cavernous sinus: |
|
|
| 13. The differential diagnostic of prolactinoma has to be made with: |
|
|
| 14. Causes of secondary hyperaldosteronism: |
|
|
| 15. Lab exam in Cushing’s shows: |
|
|
| 16. The control mechanisms of arginine vasopressin release include: |
|
|
| 17. Subclinical hyperparathyroidism has to be considered in the following situations: |
|
|
| 18. Estrogen presents the following effects: |
|
|
| 19. Combined regulation mechanisms in the endocrine system are: |
|
|
| 20. FSH has the following effects in ovaries: |
|
|
| 21. Morphofunctional imagistic test for adrenal tumors are: |
|
|
| 22. Adverse effects of the contraceptives are: |
|
|
| 23. In central diabetes insipidus : |
|
|
| 24. The following regarding pituitary are true: |
|
|
| 25. Which of the following are absolute contraindications for contraceptive use: |
|